Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
Clinical trial NCT00301951 · COMPLETED
Trial details
- NCT number
- NCT00301951
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2009-07-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.